Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website version was updated from v3.6.4 to v3.6.5, reflecting a maintenance release. This update does not alter the study details or visible content on the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a small internal version bump. No visible content or functionality changes are introduced.SummaryDifference0.1%

- Check44 days agoChange DetectedPage revision label updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page. This change does not alter the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe site software revision was updated from v3.6.0 to v3.6.2, indicating a platform update. This change does not alter the displayed study details or user-facing content.SummaryDifference0.1%

- Check65 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment is closed, and new sections How to Read a Study Record, Common Questions, and How to Join a Study were added to guide users, while the Intervention/Treatment label formatting and revision version notes were updated (v3.6.0 replacing v3.5.5).SummaryDifference0.5%

- Check73 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page. This reflects a site version update without changes to the study details.SummaryDifference0.1%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.